ARID1A Regulates Progesterone Receptor Expression in Endometrial Carcinoma and xAtypical Hyperplasia

被引：0
|
作者：
Liu, Ying [1 ]
Asaka, Shiho [2 ]
Wang, Tian-Li [1 ]
Shih, Ie-Ming [3 ]
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Shinshu Univ, Sch Med, Matsumoto, Nagano, Japan
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
MODERN PATHOLOGY | 2022年 / 35卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
733
引用
收藏
页码：790 / 790
页数：1
相关论文
共 50 条
  • [1] ARID1A Regulates Progesterone Receptor Expression in Endometrial Carcinoma and xAtypical Hyperplasia
    Liu, Ying
    Asaka, Shiho
    Wang, Tian-Li
    Shih, Ie-Ming
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 790 - 790
  • [2] ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis
    Asaka, Shiho
    Liu, Ying
    Yu, Zheng-Cheng
    Rahmanto, Yohan Suryo
    Ono, Motoki
    Asaka, Ryoichi
    Miyamoto, Tsutomu
    Yen, Ting -Tai
    Ayhan, Ayse
    Wang, Tian -Li
    Shih, Ie-Ming
    MODERN PATHOLOGY, 2023, 36 (02)
  • [3] Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma
    Yen, Ting-Tai
    Miyamoto, Tsutomu
    Asaka, Shiho
    Chui, M. Herman
    Wang, Yeh
    Lin, Shiou-Fu
    Stone, Rebecca L.
    Fader, Amanda N.
    Asaka, Ryoichi
    Kashima, Hiroyasu
    Shiozawa, Tanri
    Wang, Tian-Li
    Shih, Ie-Ming
    Tanner, Edward J., III
    GYNECOLOGIC ONCOLOGY, 2018, 150 (03) : 426 - 431
  • [4] The Clinicopathologic Significance of the Loss of BAF250a ( ARID1A) Expression in Endometrial Carcinoma
    Zhang, Zheng-mao
    Xiao, Shuang
    Sun, Guang-yu
    Liu, Yue-ping
    Zhang, Feng-hua
    Yang, Hong-fang
    Li, Jia
    Qiu, Hong-bing
    Liu, Yang
    Zhang, Chao
    Kang, Shan
    Shan, Bao-en
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (03) : 534 - 540
  • [5] Aberrant expression of progesterone receptor isoforms in endometrial hyperplasia and endometrial cancer
    Seay, Kieran
    Jin, Cao
    Beyaz, Semir
    Kapedani, Arisa
    Goldberg, Gary
    Frimer, Marina
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S193 - S194
  • [6] ARID1A expression in various molecular subgroups in endometrial carcinomas
    Evsei, A.
    Birceanu-Corobea, A.
    Ghita, M.
    Sajin, M.
    Copca, N.
    HISTOPATHOLOGY, 2022, 81 : 84 - 84
  • [7] Can ARID1A be a predictive marker of detecting endometrial carcinoma from endometrial samplings?
    Yen, T. T.
    Miyamoto, T.
    Asaka, S.
    Lin, S. F.
    Stone, R. L.
    Fader, A. N.
    Asaka, R.
    Kashima, H.
    Shiozawa, T.
    Wang, T. L.
    Shih, I. M.
    Tanne, E. J., III
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 67 - 67
  • [8] ARID1A Is a Useful Marker of Malignancy in Peritoneal Washings for Endometrial Carcinoma
    Nagymanyoki, Zoltan
    Mutter, George L.
    Hornick, Jason L.
    Cibas, Edmund S.
    CANCER CYTOPATHOLOGY, 2015, 123 (04) : 253 - 257
  • [9] Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer
    Raffone, Antonio
    Travaglino, Antonio
    Saccone, Gabriele
    Cieri, Miriam
    Mascolo, Massimo
    Mollo, Antonio
    Insabato, Luigi
    Zullo, Fulvio
    APMIS, 2019, 127 (09) : 597 - 606
  • [10] ARID1A and GPR30 expression patterns characterize the different histological subtypes of endometrial carcinoma
    Szewczuk, Wiktor
    Szewczuk, Oksana
    Czajkowski, Krzysztof
    Gornicka, Barbara
    Ilczuk, Tomasz
    Semczuk, Andrzej
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) : 1138 - 1145
12345